Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

Author:

Eggermont Alexander M.M.1,Blank Christian U.1,Mandala Mario1,Long Georgina V.1ORCID,Atkinson Victoria1,Dalle Stéphane1,Haydon Andrew1,Lichinitser Mikhail1,Khattak Adnan1,Carlino Matteo S.1,Sandhu Shahneen1,Larkin James1,Puig Susana1,Ascierto Paolo A.1,Rutkowski Piotr1,Schadendorf Dirk1,Koornstra Rutger1,Hernandez-Aya Leonel1,Maio Michele1,van den Eertwegh Alfonsus J.M.1,Grob Jean-Jacques1,Gutzmer Ralf1,Jamal Rahima1,Lorigan Paul1,Ibrahim Nageatte1,Marreaud Sandrine1,van Akkooi Alexander C.J.1,Suciu Stefan1,Robert Caroline1

Affiliation:

1. From the Gustave Roussy Cancer Campus Grand Paris and University Paris-Saclay, Villejuif (A.M.M.E., C.R.), Hospices Civils de Lyon Cancer Institute, Cancer Research Center of Lyon, Lyon University, Lyon (S.D.), and Aix-Marseille University, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille (J.-J.G.) — all in France; Netherlands Cancer Institute–Antoni van Leeuwenhoek (C.U.B., A.C.J.A.) and VU University Medical Center (A.J.M.E.), Amsterdam, and Radboud University Medical Center...

Funder

Merck Sharp and Dohme

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3